In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 30th, 2005 | 24 | Yes |
Popular Name: Quinidine Quinidine
Find On: PubMed — Wikipedia — Google
CAS Numbers: 130-89-2 , 130-95-0 , 1400-48-2 , 549-56-4 , 56-54-2 , 6151-40-2 , 6591-63-5 , 7054-25-3 , 7054-25-3, 6591-63-5 [qui , 7054-25-3, 6591-63-5 [quinidine sulfate], 56-54-2 [quinidine] , [50-54-4] , [56-54-2] , [6591-63-5]
(+)-Quinidine; 56-54-2; C06527; Quinidine
(1S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol
(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; sulfuric acid
(9S)-6'-Methoxycinchonan-9-ol sulfate
6151-40-2; CPD000857275; Quinidine hydrochloride monohydrate; SAM002264644
6151-40-2; Prestwick_589; Quinidine hydrochloride monohydrate
6591-63-5; D02272; Quinidex (TN); Quinidine sulfate (USP); Quinidine sulfate hydrate (JP16)
CPD000857275; Quinidine; Quinidine hydrochloride monohydrate; SAM002264644
METHOXYQUINOLINYLVINYLQUINUCLIDINYLMETHANO
Quinidine hydrochloride monohydrate
Quinidine sulfate salt dihydrate
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.06 | 7.47 | -38.76 | 2 | 4 | 1 | 47 | 325.432 | 4 | ↓ |
Lo Low (pH 4.5-6) | 3.06 | 7.91 | -89.66 | 3 | 4 | 2 | 48 | 326.44 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Molecular_Solubility | 5.444 | Bitter DB |
MP | 168-172° | Oakwood Chemical |
Mp [°C] | 170 - 175 | Acros Organics |
MP | 171-173° | Matrix Scientific |
MP | 172 | TCI |
ALOGPS_SOLUBILITY | 3.34e-01 g/l | DrugBank-approved |
Purity | 95% | Fluorochem |
Purity | 95+% | Matrix Scientific |
Therapy | antiarrhythmic, antimalarial | SMDC Iconix |
PUBCHEM_PATENT_ID | EP0000302A1; EP0000727A1; EP0007116A1; EP0012722A1; EP0013560A1; EP0013561A1; EP0014514A2; EP0014929A1; EP0017908A1; EP0019788A2; EP0021214A1; EP0025864A1; EP0025912A1; EP0026317A1; EP0032286A2; EP0032889A1; EP0033341A1; EP0035360A2; EP0035856A2; EP003858 | IBM Patent Data |
H phrase | H301: Toxic if swallowed | Acros Organics |
H phrase | H301: Toxic if swallowed; H315: Causes skin irritation; H319: Causes serious eye irritation; H335: May cause respiratory irritation | Acros Organics |
Warnings | IRRITANT | Matrix Scientific |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : Q-8596 | NIH Clinical Collection via PubChem |
P phrase | P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell | Acros Organics |
P phrase | P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell; P280: Wear protective gloves/protective clothing/eye protection/face protection; P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove | Acros Organics |
R phrase | R22: Harmful if swallowed. | Acros Organics |
R phrase | R22: Harmful if swallowed.; R36/37/38: Irritating to eyes, respiratory system and skin. | Acros Organics |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: Q-8596 | NIH Clinical Collection via PubChem |
Hazard | XN: Harmful | Acros Organics |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
KCNA5-1-E | Voltage-gated Potassium Channel Subunit Kv1.5 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 7300 | 0.30 | Binding ≤ 10μM |
KCND2-1-E | Potassium Voltage-gated Channel Subfamily D Member 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2200 | 0.33 | Binding ≤ 10μM |
KCNH2-5-E | HERG (cluster #5 Of 5), Eukaryotic | Eukaryotes | 6490 | 0.30 | Binding ≤ 10μM |
MDR1-2-E | P-glycoprotein 1 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 5000 | 0.31 | Binding ≤ 10μM |
SCN1A-1-E | Sodium Channel Protein Type I Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3200 | 0.32 | Binding ≤ 10μM |
SCN2A-2-E | Sodium Channel Protein Type II Alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 3200 | 0.32 | Binding ≤ 10μM |
SCN3A-1-E | Sodium Channel Protein Type III Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3200 | 0.32 | Binding ≤ 10μM |
SCN5A-1-E | Sodium Channel Protein Type V Alpha Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6900 | 0.30 | Binding ≤ 10μM |
SCN8A-1-E | Sodium Channel Protein Type VIII Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3200 | 0.32 | Binding ≤ 10μM |
MDR1-2-E | P-glycoprotein 1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 5600 | 0.31 | Functional ≤ 10μM |
CP2D6-1-E | Cytochrome P450 2D6 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 10 | 0.47 | ADME/T ≤ 10μM |
CP2DQ-1-E | Cytochrome P450 2D2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.32 | ADME/T ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 4 | 0.49 | Functional ≤ 10μM |
Z50426-6-O | Plasmodium Falciparum (isolate K1 / Thailand) (cluster #6 Of 9), Other | Other | 51 | 0.43 | Functional ≤ 10μM |
Z81138-1-O | ScN2a (Scrapie-infected Neuroblastoma Cells) (cluster #1 Of 3), Other | Other | 5000 | 0.31 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
KCNH2_HUMAN | Q12809 | HERG, Human | 323.593657 | 0.38 | Binding ≤ 1μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 323.593657 | 0.38 | Binding ≤ 10μM |
MDR1_HUMAN | P08183 | P-glycoprotein 1, Human | 2600 | 0.33 | Binding ≤ 10μM |
KCND2_RAT | Q63881 | Potassium Voltage-gated Channel Subfamily D Member 2, Rat | 2200 | 0.33 | Binding ≤ 10μM |
SCN1A_HUMAN | P35498 | Sodium Channel Protein Type I Alpha Subunit, Human | 3200 | 0.32 | Binding ≤ 10μM |
SCN2A_HUMAN | Q99250 | Sodium Channel Protein Type II Alpha Subunit, Human | 3200 | 0.32 | Binding ≤ 10μM |
SCN3A_HUMAN | Q9NY46 | Sodium Channel Protein Type III Alpha Subunit, Human | 3200 | 0.32 | Binding ≤ 10μM |
SCN5A_HUMAN | Q14524 | Sodium Channel Protein Type V Alpha Subunit, Human | 6900 | 0.30 | Binding ≤ 10μM |
SCN8A_HUMAN | Q9UQD0 | Sodium Channel Protein Type VIII Alpha Subunit, Human | 3200 | 0.32 | Binding ≤ 10μM |
KCNA5_HUMAN | P22460 | Voltage-gated Potassium Channel Subunit Kv1.5, Human | 7300 | 0.30 | Binding ≤ 10μM |
MDR1_HUMAN | P08183 | P-glycoprotein 1, Human | 2200 | 0.33 | Functional ≤ 10μM |
MDR1_MOUSE | P06795 | P-glycoprotein 1, Mouse | 10000 | 0.29 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 25.1188643 | 0.44 | Functional ≤ 10μM |
Z50426 | Z50426 | Plasmodium Falciparum (isolate K1 / Thailand) | 51 | 0.43 | Functional ≤ 10μM |
Z81138 | Z81138 | ScN2a (Scrapie-infected Neuroblastoma Cells) | 5000 | 0.31 | Functional ≤ 10μM |
CP2DQ_RAT | P10634 | Cytochrome P450 2D2, Rat | 2800 | 0.32 | ADME/T ≤ 10μM |
CP2D6_HUMAN | P10635 | Cytochrome P450 2D6, Human | 20 | 0.45 | ADME/T ≤ 10μM |
Description | Species |
---|---|
Abacavir transmembrane transport | |
ABC-family proteins mediated transport | |
CYP2E1 reactions | |
Fatty acids | |
Interaction between L1 and Ankyrins | |
Miscellaneous substrates | |
Voltage gated Potassium channels | |
Xenobiotics |
No pre-computed analogs available. Try a structural similarity search.